Are the scale… complexity… and costs of your clinical trials increasing?
Since the release of the ICH GCP Guidance updates, your answer is most likely — yes.
And, you — like many sponsors and their partners — might have limited experience with risk-based quality management approaches.
Mark your calendar for Thursday, Oct. 18, when Linda Sullivan, Co-Founder and Executive Director, Metrics Champion Consortium and Keith Dorricott, Director, Dorricott Metrics & Process Improvement Ltd, will discuss approaches sponsors are taking to align with ICH E6(R2).
During 60 fast-paced minutes Linda and Keith will:
You have to develop and implement risk-based quality management programs to comply with ICH E6(R2). You owe it to yourself to discover how … and it’s FREE. Sign up now.
Who Will Benefit
This event is designed for professionals from pharmaceutical, biotechnology and medical device companies; CROs; and other clinical service providers who have responsibilities in the following areas:
Sign Up for FREE Below
Co-Founder and Executive Director, Metrics Champion Consortium
Ms. Sullivan is Co-Founder & Executive Director of the Metrics Champion Consortium (MCC), an industry association dedicated to leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. She has more than 30 years of experience working in the Healthcare and Clinical Research industries helping organizations improve processes to improve financial and quality outcomes.
Director, Dorricott Metrics & Process Improvement Ltd
Keith Dorricott has a background in manufacturing from Kodak Ltd. He has worked in quality, metrics, process improvement and operational roles over 11 years for two major CROs. He is a Master Black Belt in Lean Sigma and is an expert in root cause analysis. He acts as facilitator for the MCC work groups including Vendor Oversight and Centralized Monitoring.